Resmed Inc (RMD) 66.25 $RMD
ResMed Up 27.0% Since SmarTrend Uptrend Call (RMD)
Comtex SmarTrend(R) - Fri Feb 13, 4:37PM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 4 months, ResMed has returned 26.96% as of today's recent price of $66.25.
RMD: 66.25 (+0.79)
ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action
PR Newswire - Thu Feb 12, 4:30PM CST
ResMed (NYSE:RMD) today announced that the Munich District Court upheld its injunction against Chinese medical device manufacturer BMC Medical Co., Ltd. (BMC). The injunction prohibits BMC from offering, selling or distributing infringing mask products in Germany.
RMD: 66.25 (+0.79)
ResMed Rises 2.07% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Feb 11, 4:39PM CST
ResMed (NYSE:RMD) traded in a range yesterday that spanned from a low of $63.95 to a high of $65.59. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $64.29 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RMD: 66.25 (+0.79)
ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:09PM CST
Through Jaysec's acquisition, ResMed (RMD) will experience reduced administrative burden owing to the self-serve software portal specifically designed for HME providers.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), RMD: 66.25 (+0.79)
These 5 Hated Stocks Could Pop in February: AT&T, Quest Diagnostics and More
at The Street - Wed Feb 11, 6:00AM CST
These heavily shorted stocks could get squeezed much higher on any positive catalyst.
VRSN: 62.15 (+0.43), T: 34.66 (+0.05), DLR: 68.65 (-2.07), RMD: 66.25 (+0.79), DGX: 71.68 (+0.03)
ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment Providers
PR Newswire - Tue Feb 10, 7:30AM CST
ResMed (NYSE:RMD) today announced it has acquired Jaysec, a provider of Internet-based software solutions for the home medical equipment (HME) industry. Headquartered in Knoxville, Tenn., Jaysec's products help HME providers resupply their patients and communicate with referring medical providers.
RMD: 66.25 (+0.79)
22.7% Return Seen to Date on SmarTrend ResMed Call (RMD)
Comtex SmarTrend(R) - Fri Feb 06, 10:58AM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 4 months, ResMed has returned 22.65% as of today's recent price of $64.00.
RMD: 66.25 (+0.79)
Insider Trading Alert - POWI, RMD And PH Traded By Insiders
at The Street - Fri Feb 06, 10:00AM CST
Stocks with insider trader activity include POWI, RMD and PH
PH: 124.06 (+2.23), RMD: 66.25 (+0.79), POWI: 54.73 (-0.30)
Easy-to-Use AirView(TM) Patient Management System by ResMed Now Integrates Directly with Brightree
PR Newswire - Mon Feb 02, 7:30AM CST
ResMed (NYSE: RMD) and Brightree today announced ResMed's AirView patient management system will directly integrate with Brightree's leading home medical equipment (HME) billing and business management software solution.
RMD: 66.25 (+0.79)
Shares of RMD Up 20.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 30, 9:40AM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 3 months, ResMed has returned 20.64% as of today's recent price of $62.95.
RMD: 66.25 (+0.79)
Health Care Equipment Equities Coverage - Volcano, Stryker, Edwards Lifesciences, ResMed, and Varian Medical Systems
PR Newswire - Wed Jan 28, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Volcano Corporation (NASDAQ: VOLC), Stryker Corporation (NYSE: SYK), Edwards Lifesciences Corporation (NYSE: EW), ResMed Inc. (NYSE: RMD), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on Pan American Silver can be accessed at http://get.Investor-Edge.com/pdf/?c=Pan%20Ame...amp;s=PAAS. The US markets declined on Tuesday, January 27, 2015, as the Dow Jones Industrial Average finished at 17,387.21, down 1.65% and the NASDAQ Composite closed at 4,681.50, down 1.89%. The S&P 500 finished the session 1.34% lower at 2,029.55. During the trading session, nine out of ten sectors finished on a negative note. The S&P 500 Health Care Sector Index ended the day at 818.80, down 0.75%, whereas the index has gained 8.40% in the previous three months. Register for your complimentary reports at the links given below.
VAR: 92.65 (+0.03), RMD: 66.25 (+0.79), VOLC: 17.98 (+0.03), EW: 134.23 (+1.89), MDSY: 2.97 (+0.02), SYK: 94.51 (+1.14)
Critical Alerts For Infinera Corporation, Pandora, Trulia, ResMed and Amgen Released By InvestorsObserver
PR Newswire - Mon Jan 26, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for INFN, P, TRLA, RMD and AMGN.
P: 15.44 (+0.45), RMD: 66.25 (+0.79), AMGN: 153.48 (+0.30), TRLA: 46.89 (+0.74), INFN: 17.56 (-0.10)
ResMed (RMD) Beats Q2 Earnings & Revenues, Margin Falls - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 8:00AM CST
Currently, ResMed (RMD) is engaged in executing its three horizons growth strategy of improving patient quality-of-life, lowering healthcare costs, and preventing chronic disease progression.
ICUI: 88.98 (+0.42), CSII: 35.69 (+0.17), CNAT: 5.92 (+0.10), RMD: 66.25 (+0.79)
After Yesterday's Rally of 5.46% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Jan 23, 3:40PM CST
ResMed (NYSE:RMD) traded in a range yesterday that spanned from a low of $63.65 to a high of $67.50. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $61.95 on volume of 5.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RMD: 66.25 (+0.79)
ResMed Stock Hits High As Growth Reignites
at Investor's Business Daily - Fri Jan 23, 11:49AM CST
Medical-device maker ResMed (RMD) vaulted to a new high Friday after its fiscal Q2 results beat estimates late Thursday. For the quarter ended Dec. 31, ResMed earning 65 cents a share, up 6.6% from the year-earlier quarter and beating estimates by 4...
RMD: 66.25 (+0.79)
ResMed (RMD) Stock Continues to Rise Today on Strong Quarterly Results
at The Street - Fri Jan 23, 10:18AM CST
ResMed (RMD) shares are rising after the company beat analysts' second quarter earnings and revenue expectations.
RMD: 66.25 (+0.79)
ResMed Shares Up 25.7% Since SmarTrend's Buy Recommendation (RMD)
Comtex SmarTrend(R) - Fri Jan 23, 9:16AM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 3 months, ResMed has returned 25.72% as of today's recent price of $65.60.
RMD: 66.25 (+0.79)
Upgrade Alert for ResMed (RMD)
Comtex SmarTrend(R) - Fri Jan 23, 6:53AM CST
ResMed (NYSE:RMD) was upgraded from Hold to Buy at Needham today. The stock closed yesterday at $61.86 on volume of 2.0 million shares, above average daily volume of 1.1 million. Over the past year, ResMed has traded in a range of $41.52 to $61.95 and closed yesterday at $61.86, 49% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.0% while the 200-day MA has risen 0.5%.
RMD: 66.25 (+0.79)
ResMed FQ2 revenues up 10%
Seeking Alpha - at Seeking Alpha - Fri Jan 23, 5:22AM CST
RMD: 66.25 (+0.79)
ResMed's (RMD) CEO Michael Farrell on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 22, 10:12PM CST
RMD: 66.25 (+0.79)
ResMed Up 27.0% Since SmarTrend Uptrend Call (RMD)
Comtex SmarTrend(R) - Fri Feb 13, 4:37PM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 4 months, ResMed has returned 26.96% as of today's recent price of $66.25.
RMD: 66.25 (+0.79)
ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action
PR Newswire - Thu Feb 12, 4:30PM CST
ResMed (NYSE:RMD) today announced that the Munich District Court upheld its injunction against Chinese medical device manufacturer BMC Medical Co., Ltd. (BMC). The injunction prohibits BMC from offering, selling or distributing infringing mask products in Germany.
RMD: 66.25 (+0.79)
ResMed Rises 2.07% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Feb 11, 4:39PM CST
ResMed (NYSE:RMD) traded in a range yesterday that spanned from a low of $63.95 to a high of $65.59. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $64.29 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RMD: 66.25 (+0.79)
ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:09PM CST
Through Jaysec's acquisition, ResMed (RMD) will experience reduced administrative burden owing to the self-serve software portal specifically designed for HME providers.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), RMD: 66.25 (+0.79)
These 5 Hated Stocks Could Pop in February: AT&T, Quest Diagnostics and More
at The Street - Wed Feb 11, 6:00AM CST
These heavily shorted stocks could get squeezed much higher on any positive catalyst.
VRSN: 62.15 (+0.43), T: 34.66 (+0.05), DLR: 68.65 (-2.07), RMD: 66.25 (+0.79), DGX: 71.68 (+0.03)
ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment Providers
PR Newswire - Tue Feb 10, 7:30AM CST
ResMed (NYSE:RMD) today announced it has acquired Jaysec, a provider of Internet-based software solutions for the home medical equipment (HME) industry. Headquartered in Knoxville, Tenn., Jaysec's products help HME providers resupply their patients and communicate with referring medical providers.
RMD: 66.25 (+0.79)
22.7% Return Seen to Date on SmarTrend ResMed Call (RMD)
Comtex SmarTrend(R) - Fri Feb 06, 10:58AM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 4 months, ResMed has returned 22.65% as of today's recent price of $64.00.
RMD: 66.25 (+0.79)
Insider Trading Alert - POWI, RMD And PH Traded By Insiders
at The Street - Fri Feb 06, 10:00AM CST
Stocks with insider trader activity include POWI, RMD and PH
PH: 124.06 (+2.23), RMD: 66.25 (+0.79), POWI: 54.73 (-0.30)
Easy-to-Use AirView(TM) Patient Management System by ResMed Now Integrates Directly with Brightree
PR Newswire - Mon Feb 02, 7:30AM CST
ResMed (NYSE: RMD) and Brightree today announced ResMed's AirView patient management system will directly integrate with Brightree's leading home medical equipment (HME) billing and business management software solution.
RMD: 66.25 (+0.79)
Shares of RMD Up 20.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 30, 9:40AM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 3 months, ResMed has returned 20.64% as of today's recent price of $62.95.
RMD: 66.25 (+0.79)
Health Care Equipment Equities Coverage - Volcano, Stryker, Edwards Lifesciences, ResMed, and Varian Medical Systems
PR Newswire - Wed Jan 28, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Volcano Corporation (NASDAQ: VOLC), Stryker Corporation (NYSE: SYK), Edwards Lifesciences Corporation (NYSE: EW), ResMed Inc. (NYSE: RMD), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on Pan American Silver can be accessed at http://get.Investor-Edge.com/pdf/?c=Pan%20Ame...amp;s=PAAS. The US markets declined on Tuesday, January 27, 2015, as the Dow Jones Industrial Average finished at 17,387.21, down 1.65% and the NASDAQ Composite closed at 4,681.50, down 1.89%. The S&P 500 finished the session 1.34% lower at 2,029.55. During the trading session, nine out of ten sectors finished on a negative note. The S&P 500 Health Care Sector Index ended the day at 818.80, down 0.75%, whereas the index has gained 8.40% in the previous three months. Register for your complimentary reports at the links given below.
VAR: 92.65 (+0.03), RMD: 66.25 (+0.79), VOLC: 17.98 (+0.03), EW: 134.23 (+1.89), MDSY: 2.97 (+0.02), SYK: 94.51 (+1.14)
Critical Alerts For Infinera Corporation, Pandora, Trulia, ResMed and Amgen Released By InvestorsObserver
PR Newswire - Mon Jan 26, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for INFN, P, TRLA, RMD and AMGN.
P: 15.44 (+0.45), RMD: 66.25 (+0.79), AMGN: 153.48 (+0.30), TRLA: 46.89 (+0.74), INFN: 17.56 (-0.10)
ResMed (RMD) Beats Q2 Earnings & Revenues, Margin Falls - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 8:00AM CST
Currently, ResMed (RMD) is engaged in executing its three horizons growth strategy of improving patient quality-of-life, lowering healthcare costs, and preventing chronic disease progression.
ICUI: 88.98 (+0.42), CSII: 35.69 (+0.17), CNAT: 5.92 (+0.10), RMD: 66.25 (+0.79)
After Yesterday's Rally of 5.46% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Jan 23, 3:40PM CST
ResMed (NYSE:RMD) traded in a range yesterday that spanned from a low of $63.65 to a high of $67.50. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $61.95 on volume of 5.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RMD: 66.25 (+0.79)
ResMed Stock Hits High As Growth Reignites
at Investor's Business Daily - Fri Jan 23, 11:49AM CST
Medical-device maker ResMed (RMD) vaulted to a new high Friday after its fiscal Q2 results beat estimates late Thursday. For the quarter ended Dec. 31, ResMed earning 65 cents a share, up 6.6% from the year-earlier quarter and beating estimates by 4...
RMD: 66.25 (+0.79)
ResMed (RMD) Stock Continues to Rise Today on Strong Quarterly Results
at The Street - Fri Jan 23, 10:18AM CST
ResMed (RMD) shares are rising after the company beat analysts' second quarter earnings and revenue expectations.
RMD: 66.25 (+0.79)
ResMed Shares Up 25.7% Since SmarTrend's Buy Recommendation (RMD)
Comtex SmarTrend(R) - Fri Jan 23, 9:16AM CST
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on October 24th, 2014 at $52.18. In approximately 3 months, ResMed has returned 25.72% as of today's recent price of $65.60.
RMD: 66.25 (+0.79)
Upgrade Alert for ResMed (RMD)
Comtex SmarTrend(R) - Fri Jan 23, 6:53AM CST
ResMed (NYSE:RMD) was upgraded from Hold to Buy at Needham today. The stock closed yesterday at $61.86 on volume of 2.0 million shares, above average daily volume of 1.1 million. Over the past year, ResMed has traded in a range of $41.52 to $61.95 and closed yesterday at $61.86, 49% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.0% while the 200-day MA has risen 0.5%.
RMD: 66.25 (+0.79)
ResMed FQ2 revenues up 10%
Seeking Alpha - at Seeking Alpha - Fri Jan 23, 5:22AM CST
RMD: 66.25 (+0.79)
ResMed's (RMD) CEO Michael Farrell on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 22, 10:12PM CST
RMD: 66.25 (+0.79)
